Literature DB >> 8376685

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators.

M G Bourassa1, O Gurné, S I Bangdiwala, J K Ghali, J B Young, M Rousseau, D E Johnstone, S Yusuf.   

Abstract

A total of 6,273 consecutive relatively unselected patients with heart failure or left ventricular dysfunction, or both (mean age 62 +/- 12 years, mean ejection fraction 31 +/- 9%), were enrolled in the Studies of Left Ventricular Dysfunction (SOLVD) Registry over a period of 14 months. All patients were followed up for vital status and hospital admissions at 1 year. Ischemic heart disease was the underlying cause of failure or dysfunction in approximately 70% of patients, whereas hypertensive heart disease was considered to be primarily involved in only 7%. There were striking differences in the etiology of heart failure among blacks and whites: 73% of whites had an ischemic etiology of failure versus only 36% of blacks; 32% of blacks had a hypertensive condition versus only 4% of whites. The total 1-year mortality rate was 18%; 19% of patients had hospital admissions for heart failure and 27% either died or had a hospital admission for congestive heart failure during the 1st year of follow-up. Factors related to 1-year mortality or hospital admission for congestive heart failure included age, ejection fraction, diabetes mellitus, atrial fibrillation and female gender. There was no difference in mortality associated with congestive heart failure among blacks and whites, but hospital admissions for heart failure were more frequent in blacks. Digitalis and diuretic agents were the drugs most often used in these patients, who were often taking many medications in relation to severity of congestive heart failure symptoms and ejection fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8376685     DOI: 10.1016/0735-1097(93)90456-b

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  49 in total

Review 1.  PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.

Authors:  Liesbet Mesotten; Alex Maes; Frans Van de Werf; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2001-11-14       Impact factor: 9.236

Review 2.  Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?

Authors:  Kirkwood F Adams
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

3.  Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System.

Authors:  Matthew S Durstenfeld; Olugbenga Ogedegbe; Stuart D Katz; Hannah Park; Saul Blecker
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

4.  A dynamic Mover-Stayer model for recurrent event processes subject to resolution.

Authors:  Hua Shen; Richard J Cook
Journal:  Lifetime Data Anal       Date:  2013-06-20       Impact factor: 1.588

Review 5.  The management of conditioned nutritional requirements in heart failure.

Authors:  Marc L Allard; Khursheed N Jeejeebhoy; Michael J Sole
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

6.  Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?

Authors:  M A Scheiner; S E Kimmel
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

7.  Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction.

Authors:  Longhu Li; Husnain Kh Haider; Linlin Wang; Gang Lu; Muhammad Ashraf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

8.  Randomised trial of telephone intervention in chronic heart failure: DIAL trial.

Authors: 
Journal:  BMJ       Date:  2005-08-20

9.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

10.  NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.

Authors:  Stefan Gattenlöhner; Christiane Waller; Georg Ertl; Burkhard-Dieter Bültmann; Hans-Konrad Müller-Hermelink; Alexander Marx
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.